Alphaeon will acquire medical device company Lensar in a transaction valued up to $59 million.

Lensar is a manufacturer of the Femtosecond lasers systems for cataract treatment. Its Lensar system is designed for patients seeking an enhanced vision outcome following the removal of their crystalline lens.

The transaction is subject to the completion of certain closing conditions on or before December 31. — Michael Cipriano